Provided by Tiger Trade Technology Pte. Ltd.

Pyxis Oncology, Inc.

2.14
-0.0500-2.28%
Post-market: 2.150.0092+0.43%19:30 EDT
Volume:2.00M
Turnover:4.36M
Market Cap:178.49M
PE:-1.53
High:2.31
Open:2.21
Low:2.10
Close:2.19
52wk High:5.55
52wk Low:1.03
Shares:83.41M
Float Shares:70.69M
Volume Ratio:0.83
T/O Rate:2.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4029
EPS(LYR):-1.2813
ROE:-179.10%
ROA:-62.95%
PB:15.60
PE(LYR):-1.67

Loading ...

Genelux Posts Wider-than-Expected Q2 Loss on Higher R&D Expenses

Reuters
·
Aug 14

NuCana Q2 Loss Narrows as Clinical Milestones Remain on Track

Reuters
·
Aug 14

Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS)

TIPRANKS
·
Aug 14

U.S. Stocks on the MOVE-EnerSys, Netflix, Salesforce

Reuters
·
Aug 14

Pyxis Oncology Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Pyxis Oncology Falls After Wider-than-Expected Quarterly Loss

Reuters
·
Aug 13

Pyxis Oncology Posts Corporate Deck Spotlighting MICVO Extracellular-Targeting ADC in Head-and-Neck Cancer

Reuters
·
Aug 13

Pyxis Oncology Q2 Loss Widens on Increased Administrative Costs

Reuters
·
Aug 13

Pyxis Oncology Q2 EPS $(0.40) Misses $(0.35) Estimate

Benzinga Earnings
·
Aug 13

Pyxis Oncology Q2 Net Income USD -25.346 Million

Reuters
·
Aug 13

Pyxis Oncology Q2 Operating Expenses USD 25.99 Million

THOMSON REUTERS
·
Aug 13

Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances Micvo Toward Key 2026 Clinical Milestones

THOMSON REUTERS
·
Aug 13

Press Release: Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Dow Jones
·
Aug 13

NASDAQ Trade Halt Volatility Trading Pause at 12:27 Pm

Reuters
·
Aug 12

Pyxis Oncology Inc Expected to Post a Loss of 35 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Pyxis Oncology Initiated at Overweight by Wells Fargo

Dow Jones
·
Aug 03

Wells Fargo Initiates Pyxis Oncology at Overweight With $12 Price Target

MT Newswires Live
·
Aug 03

Pyxis Oncology Files Form 3 Beneficial Ownership Statement for Gordonmd Global Investments LP

Reuters
·
Jul 11

Analysts’ Top Healthcare Picks: Pyxis Oncology (PYXS), Pfizer (PFE)

TIPRANKS
·
Jul 03

Pyxis Oncology Director Jakob Dupont Disposes of 35,000 Common Shares Worth $107,100

Reuters
·
Jul 03